Main page content

Displaying results 1 - 7 of 7
Publication ID: SMA16-4932
Published:

This manual for administrators describes the influence of culture on the delivery of substance use and mental health services. It discusses racial, ethnic, and cultural considerations, and presents the core elements of cultural competence.

Publication ID: SMA16-4931
Published:

This manual for clinicians describes the influence of culture on the delivery of substance use and mental health services. It discusses racial, ethnic, and cultural considerations, and presents the core elements of cultural competence.

Publication ID: SMA13-4794
Published:

This quick guide helps clinicians address viral hepatitis when working with people living with substance use disorders. It covers hepatitis prevention, screening, treatment, and service coordination, and guides administrators on how to add or improve hepatitis services.

Publication ID: SMA13-4786
Published:

This guide helps clinicians of substance use disorder treatment facilities implement programs that address suicidal thoughts in patients with substance use disorders. It covers legal and ethical issues, referrals, as well as privacy and confidentiality.

Publication ID: SMA13-4793
Published:

This quick guide helps clinicians and other service providers address suicide and suicide prevention in patients living with substance use disorders. It covers risk factors and warning signs for suicide, core competencies, and information for administrators and clinical supervisors.

Publication ID: SMA13-4788
Published:

This quick guide helps administrators of substance use disorder treatment facilities implement programs and services that address the needs of women living with substance use disorders. It addresses patterns of use and the drug screening and treatment needs of women.

Publication ID: SMA10-4542
Published:

This manual guides counselors in the use of medications to help clients achieve abstinence from alcohol. It describes how the medications work and whom may benefit. It also presents the side effects of three FDA-approved medications: acamprosate, disulfiram, and naltrexone.